89 results
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
be offset by the amount of any statutory or contractual severance and notice entitlements. Benefit continuation will be provided for the applicable severance … , as appropriate, and an interest charge would be imposed on the tax attributable to the allocated amount. U.S. Holders would not be able to offset any
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
and the increase in interest rates, offset in part by lower foreign exchange gain of $868,000 in the current period resulting from the conversion in U.S. dollars
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
investments position following the July 2022 Offering and the increase in interest rates, offset in part by a lower foreign exchange gain
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
option plan as well as to an increase in external G&A expense, partially offset by higher interest income on the Company’s cash, cash equivalents … of our CALM Phase 3 clinical program in 2022, offset in part by higher stock-based compensation expense of $1,985,000 in relation to our stock option
6-K
EX-99.2
BLU
Bellus Health Inc
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
as to an increase in external G&A expense, partially offset by a decrease in external R&D spend.
Research and development expenses, net of research tax credits … . The decrease is partially offset by higher expenses due to our increased workforce to support the next steps in our development plans for BLU-5937 as well
SUPPL
ixv v4cyrkepf3
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
jvc9q0a t503
14 Nov 22
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
4:03pm
F-10
r8ui imhdyzi
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.2
069lwd6d6t90p
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.1
as1 7n64k69nf
10 Aug 22
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
4:31pm
SUPPL
8p02bwjx urc
15 Jul 22
Supplemental materials (foreign)
7:01am
SUPPL
tdmpu0dfjciwak8d8ni
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
vig7q8yjxw39nuc7ldsd
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
S-8
roc6qtd74efllhdw
19 Apr 22
Registration of securities for employees
4:14pm
6-K
EX-99.1
bxxzk hm7lnudlq
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.3
xxar2c 1pyc60c
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.2
69c5l2jp
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.1
waozp
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
SUPPL
o3et0e
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
emxqhfn 5873b5vjpt
14 Dec 21
Registration of securities (Canada)
9:43am